Heart Failure as the First Clinical Manifestation of Basedow’s Disease

1. Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol. 2018;71:1781–1796. doi: 10.1016/j.jacc.2018.02.045 RazviS JabbarA PingitoreA Thyroid Hormones and Cardiovascular Function and Diseases J Am Coll Cardiol 2018 71 1781 1796 10.1016/j.jacc.2018.02.045 Open DOISearch in Google Scholar

2. Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. Treasure Island (FL): StatPearls; https://www.ncbi.nlm.nih.gov/books/NBK500006/ (5 Jun 2023) ShahidMA AshrafMA SharmaS Physiology, Thyroid Hormone Treasure Island (FL) StatPearls https://www.ncbi.nlm.nih.gov/books/NBK500006/ (5 Jun 2023) Search in Google Scholar

3. Nappi A, Murolo M, Sagliocchi S, et al. Selective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic Behavior. Int J Mol Sci. 2021;22(13):7175. doi: 10.3390/ijms22137175 NappiA MuroloM SagliocchiS Selective Inhibition of Genomic and Non-Genomic Effects of Thyroid Hormone Regulates Muscle Cell Differentiation and Metabolic Behavior Int J Mol Sci 2021 22 13 7175 10.3390/ijms22137175 Open DOISearch in Google Scholar

4. Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014;26(6):296–309. doi: 10.1016/j.arteri.2014.07.003 Vargas-UricoecheaH Bonelo-PerdomoA Sierra-TorresCH Effects of thyroid hormones on the heart Clin Investig Arterioscler 2014 26 6 296 309 10.1016/j.arteri.2014.07.003 Open DOISearch in Google Scholar

5. von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A. The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect. 2019;8(5):R76–R90. doi: 10.1530/EC-19-0096 von HafeM NevesJS ValeC Borges-CanhaM Leite-MoreiraA The impact of thyroid hormone dysfunction on ischemic heart disease Endocr Connect 2019 8 5 R76 R90 10.1530/EC-19-0096 Open DOISearch in Google Scholar

6. Arslan A, Altay H. Graves’ Disease and Cardiac Complications [Internet]. Graves’ Disease. IntechOpen; 2021. doi: 10.5772/intechopen.97128 ArslanA AltayH Graves’ Disease and Cardiac Complications [Internet]. Graves’ Disease IntechOpen 2021 10.5772/intechopen.97128 Open DOISearch in Google Scholar

7. López Ortega JM, Martínez PS, Acevedo-León D, Capell NE. Anti-TSH receptor antibodies (TRAb): Comparison of two third-generation automated immunoassays broadly used in clinical laboratories and results interpretation. PLoS One. 2022;17(7):e0270890. doi: 10.1371/journal.pone.0270890 López OrtegaJM MartínezPS Acevedo-LeónD CapellNE Anti-TSH receptor antibodies (TRAb): Comparison of two third-generation automated immunoassays broadly used in clinical laboratories and results interpretation PLoS One 2022 17 7 e0270890 10.1371/journal.pone.0270890 Open DOISearch in Google Scholar

8. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. doi: 10.1097/HJH.0000000000003480 ManciaG KreutzR BrunströmM 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J Hypertens 2023 41 12 1874 2071 10.1097/HJH.0000000000003480 Open DOISearch in Google Scholar

9. Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J. 2018;7(4):167–186. doi: 10.1159/000490384 KahalyGJ BartalenaL HegedüsL 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism Eur Thyroid J 2018 7 4 167 186 10.1159/000490384 Open DOISearch in Google Scholar

10. Abdi H, Amouzegar A, Azizi F. Antithyroid Drugs. Iran J Pharm Res. 2019 Fall;18(Suppl1):1–12. doi: 10.22037/ijpr.2020.112892.14005 AbdiH AmouzegarA AziziF Antithyroid Drugs Iran J Pharm Res 2019 Fall 18 Suppl1 1 12 10.22037/ijpr.2020.112892.14005 Open DOISearch in Google Scholar

11. Ngassam E, Azabji-Kenfack M, Tankeu AT, et al. Heart rate variability in hyperthyroidism on sub Saharan African patients: a case–control study. BMC Res Notes. 2018;11(1):814. doi: 10.1186/s13104-018-3922-4 NgassamE Azabji-KenfackM TankeuAT Heart rate variability in hyperthyroidism on sub Saharan African patients: a case–control study BMC Res Notes 2018 11 1 814 10.1186/s13104-018-3922-4 Open DOISearch in Google Scholar

12. Kotadia ID, Williams SE, O'Neill M. Supraventricular tachycardia: An overview of diagnosis and management. Clin Med. 2020;20(1):43–47. doi: 10.7861/clinmed.cme.20.1.3 KotadiaID WilliamsSE O'NeillM Supraventricular tachycardia: An overview of diagnosis and management Clin Med 2020 20 1 43 47 10.7861/clinmed.cme.20.1.3 Open DOISearch in Google Scholar

13. Henning A, Krawiec C. Sinus Tachycardia. In: StatPearls [Internet]. Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK553128/ (5 Mar 2023) HenningA KrawiecC Sinus Tachycardia In: StatPearls [Internet] Treasure Island (FL) https://www.ncbi.nlm.nih.gov/books/NBK553128/ (5 Mar 2023) Search in Google Scholar

14. Navarro-Navajas A, Cruz JD, Ariza-Ordoñez N, et al. Cardiac manifestations in hyperthyroidism. Rev Cardiovasc Med. 2022;23(4):135–136. doi: 10.31083/j.rcm2304136 Navarro-NavajasA CruzJD Ariza-OrdoñezN Cardiac manifestations in hyperthyroidism Rev Cardiovasc Med 2022 23 4 135 136 10.31083/j.rcm2304136 Open DOISearch in Google Scholar

15. Brugada J, Katritsis DG, Arbelo E, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655–720. doi: 10.1093/eurheartj/ehz467 BrugadaJ KatritsisDG ArbeloE ESC Scientific Document Group 2019 ESC Guidelines for the management of patients with supraventricular tachycardia Eur Heart J 2020 41 5 655 720 10.1093/eurheartj/ehz467 Open DOISearch in Google Scholar

16. Elias RM, Dean DS, Barsness GW. Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience ISRN Endocrinol. 2012;2012:325092. doi: 10.5402/2012/325092 EliasRM DeanDS BarsnessGW Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience ISRN Endocrinol 2012 2012 325092 10.5402/2012/325092 Open DOISearch in Google Scholar

17. Abdulrahman RM, Delgado V, Ng AC, et al. Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging. Eur J Endocrinol. 2010;163(3):435–441. doi: 10.1530/EJE-10-0328 AbdulrahmanRM DelgadoV NgAC Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging Eur J Endocrinol 2010 163 3 435 441 10.1530/EJE-10-0328 Open DOISearch in Google Scholar

18. Lanspa MJ, Shahul S, Hersh A, et al. Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients. Ann Intensive Care. 2017;7(1):17. doi: 10.1186/s13613-017-0240-2 LanspaMJ ShahulS HershA Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients Ann Intensive Care 2017 7 1 17 10.1186/s13613-017-0240-2 Open DOISearch in Google Scholar